openPR Logo
Press release

Contraceptives Market is Expanding at a 6.1% CAGR between 2017 and 2025

08-24-2018 03:08 PM CET | Health & Medicine

Press release from: Transparency Market Research

Contraceptives Market is Expanding at a 6.1% CAGR between 2017

Global Contraceptives Market: Snapshot

The global contraceptives market is gaining from the increasing number of awareness campaigns that propagate contraceptives to be the effective method to prevent unintended pregnancy. Celebrity endorsements of these campaigns is particularly favoring the use of contraceptives among young adults who have the mindset to imitate famous people.

In urban areas, modern education and career aspirations have been crucial factors for the increasing use of contraceptives. Increasing number of women in the workforce and practices of seeking expert help for delayed pregnancy are driving the adoption of contraceptives.

Proving to challenge the market’s growth are side effects associated with hormonal contraception which is slowing their adoption among wary consumers.

Obtain Report Details @ https://www.transparencymarketresearch.com/contraceptives-market.html

As per a report by Transparency Market Research, the global contraceptives market is likely to rise at a CAGR of 6.1% between 2017 and 2025, for the market to be evaluated at US$37,242.7 mn by the end of 2025 from its worth of US$22,050.0 mn in 2016.

Contraceptive Devices Preferred due to Attributes of Effective, Long Lasting Contraception

In this report, the global contraceptives market is studied on the basis of product type, distribution channel, and region. On the basis of product type, the segments into which this market is divided are contraceptive drugs and contraceptive devices. The segment of contraceptive drugs is further sub-segmented into oral contraceptive, contraceptive injectable, and topical contraceptive patch. Oral contraceptive is further segmented into combined contraceptives and mini pills.

Contraceptive devices is segmented into male contraceptives and female contraceptives. Female contraceptives is further sub-segmented into female condoms, contraceptive sponges, contraceptive diaphragms, contraceptive vaginal rings, sub-dermal contraceptive plants, intrauterine devices, and non-surgical permanent contraception devices. The segment of contraceptive devices dominate the overall market, with the segment holding the leading 53.2% market share in 2016. This is mainly because of rising demand for intrauterine devices due to their safe, effective, and long lasting contraceptive benefits.

Request For Sample of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=344

The segment of oral contraceptives within contraceptive drugs is anticipated to register the leading growth over the forecast period. This is attributed to the ease of availability of oral contraception, increasing awareness of pills among women, and development of low cost generic drugs.

Based on distribution channel, the global contraceptives market is segmented into hospitals pharmacy, independent pharmacy, online platform, clinics, and others. Hospital pharmacy is further segmented into public and private. Among the key distribution channel segments, hospital pharmacy leads the overall contraceptives market. Hospital pharmacy held the leading 34.7% market share in 2016 backed by favorable public and private funding and reimbursement facility for contraception treatment and ease in access of over the counter and prescribed drug at hospital pharmacy.

Asia Pacific to Emerge as Significant Market in Future

The global contraceptives market has been segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa based on geography. North America leads among other key regional markets with the region holding a share of 35.0% in 2016. The factors contributing to the growth of North America contraceptives market include rising prevalence of unintended pregnancies, rising trend of delayed child bearing, and growing usage of contraceptives among teenagers.

Request For Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=344

Europe stood as the second-leading region for contraceptives in 2016. The growth of this market is mainly due to easy availability of modern contraceptives and reimbursement provision for long term reversible contraceptive treatment.

However, Asia Pacific is projected to display the leading growth rate over the forecast period. Government initiatives to raise awareness to prevent unintended pregnancies, extensive population base in China and India creating massive demand for contraceptives, and rapid economic development are factors that will contribute to the growth of Asia Pacific contraceptives market.

Leading players in the global contraceptives market include Cipla Inc., Bayer AG, Merck Co. Inc., Teva Pharmaceutical Industries Ltd., Allergan plc, Pfizer Inc., Reckitt Benckiser plc, Mankind Pharma, Janssen Pharmaceutical Company, HLL Lifecare Limited, and Mithra Pharmaceuticals among others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Contraceptives Market is Expanding at a 6.1% CAGR between 2017 and 2025 here

News-ID: 1200585 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Contraceptive

Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones
Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the
Global Contraceptives Drugs And Devices Market, By Product Type (Contraceptive D …
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects. The use of contraceptives can avoid
Oral Contraceptive Pills Market: Snapshot
Teva Pharmaceutical is one of the leading companies in the combination oral contraceptive pills segment and is followed by Allergan (Actavis) plc. Local manufacturers such as Alkem, Taj Pharma, and Zydus Alidec on the other hand, held a majority of the market for ormeloxifene and mifepristone. Transparency Market Research has observed that almost all manufacturers offer combination oral contraceptive pills owing to the fact that they are more efficient, cost